CCS: Chromosomal Screening

Comprehensive Chromosomal Screening (CCS)

Comprehensive Chromosomal Screening (CCS) is a revolutionary technique that vastly improves successful outcomes for our patients. The screening method allows for more successful implantations, helps to reduce the chances of miscarriage, and decreases the risk of multiple births from In-Vitro Fertilization (IVF).

What is Comprehensive Chromosomal Screening?

CCS allows doctors to choose the healthiest embryo from a group of embryos. During CCS, the embryo is analyzed for any abnormalities in the chromosomes. After careful analysis, only the best embryo(s) are selected for use in IVF.

How does Comprehensive Chromosomal Screening work?

To perform CCS, our embryology team extracts a few cells from the day 5 or day 6 blastocyst using a cell biopsy. This process does not harm the embryo, but does allow doctors to examine the cells closely for abnormalities and signs of poor health. Any embryos with abnormalities are separated, and the healthiest embryos are set aside for transfer to the uterus.

Why use Comprehensive Chromosomal Screening?

CCS helps reduce some of the most common risks associated with IVF by identifying chromosome abnormalities prior to transferring an embryo to the uterus. These abnormalities cause more than 60 percent of miscarriages and are also responsible for a number of failed pregnancies from IVF.

Although multiples is still a possibility, embryo selection is an important way to help reduce this risk. Doctors can feel more confident in the health of the embryos they are transferring to the patient, and therefore do not need to transfer additional embryos to compensate. CCS is also useful in identifying serious genetic disorders like Down syndrome.